Beverly D. Smolich

2.2k total citations · 1 hit paper
17 papers, 1.7k citations indexed

About

Beverly D. Smolich is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Beverly D. Smolich has authored 17 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Hematology and 3 papers in Genetics. Recurrent topics in Beverly D. Smolich's work include Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Connexins and lens biology (3 papers). Beverly D. Smolich is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Connexins and lens biology (3 papers). Beverly D. Smolich collaborates with scholars based in United States and Australia. Beverly D. Smolich's co-authors include Julie M. Cherrington, Kevin Yee, Michael C. Heinrich, William C. Manning, Sharianne G. Louie, John W. Taylor, Tinya J. Abrams, Leslie B. Lee, Lesley Murray and Ajia Town and has published in prestigious journals such as Blood, Molecular and Cellular Biology and Oncogene.

In The Last Decade

Beverly D. Smolich

17 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo

2003 703 citations Tinya J. Abrams, Sharianne G. Louie et al. Blood profile →

Peers

Countries citing papers authored by Beverly D. Smolich

Since Specialization

Citations

This map shows the geographic impact of Beverly D. Smolich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly D. Smolich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly D. Smolich more than expected).

Fields of papers citing papers by Beverly D. Smolich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly D. Smolich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly D. Smolich. The network helps show where Beverly D. Smolich may publish in the future.

Co-authorship network of co-authors of Beverly D. Smolich

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly D. Smolich. A scholar is included among the top collaborators of Beverly D. Smolich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly D. Smolich. Beverly D. Smolich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Gene expression profiling of human colon xenograft tumors following treatment with SU11248, a multitargeted tyrosine kinase inhibitor 2004 ·Oncogene ·Alyssa Morimoto, Nguyêñ Duy Tân, Kristina West, Grant A. McArthur, Guy C. Toner, William C. Manning, Beverly D. Smolich, Julie M. Cherrington	37
2	Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia 2004 ·Leukemia Research ·Anne-Marie O’Farrell, (unknown), Beverly D. Smolich, Alison L. Hannah, Sharianne G. Louie, (unknown), Alison Stopeck, Lewis R. Silverman, Jeffrey E. Lancet, Judith E. Karp, Maher Albitar, Julie M. Cherrington, Francis J. Giles	58
3	Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification 2003 ·BMC Cancer ·Samuel E. DePrimo, (unknown), Deepak Khatry, (unknown), William C. Manning, Beverly D. Smolich, Anne-Marie O’Farrell, Julie M. Cherrington	77
4	SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo breakdown → 2003 ·Blood ·(unknown), Tinya J. Abrams, (unknown), (unknown), Sharianne G. Louie, Kevin Yee, (unknown), (unknown), Leslie B. Lee, Ajia Town, Beverly D. Smolich, William C. Manning, Lesley Murray, Michael C. Heinrich, Julie M. Cherrington	703
5	SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase 2002 ·Blood ·Kevin Yee, A O’Farrell, Beverly D. Smolich, Julie M. Cherrington, Gerald McMahon, Cecily L. Wait, Laura McGreevey, Diana Griffith, Michael C. Heinrich	140
6	The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts 2001 ·Blood ·Beverly D. Smolich, (unknown), Kristina West, Francis J. Giles, Maher Albitar, Julie M. Cherrington	157
7	Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent. 2000 ·PubMed ·Dirk B. Mendel, Alexander Laird, Beverly D. Smolich, Rodrigo Blake, (unknown), Alison L. Hannah, Raymond M. Shaheen, L. M. Ellis, Steve Weitman, Laura K. Shawver, Julie M. Cherrington	189
8	Cloning and Biochemical Characterization of LIMK-2, a Protein Kinase Containing Two LIM Domains 1997 ·The Journal of Biochemistry ·Beverly D. Smolich, Manh-Cuong Vo, (unknown), Gregory D. Plowman, J Papkoff	12
9	Regulated Expression of Wnt Family Members during Neuroectodermal Differentiation of P19 Embryonal Carcinoma Cells: Overexpression of Wnt-1 Perturbs Normal Differentiation-Specific Properties 1994 ·Developmental Biology ·Beverly D. Smolich, Jackie Papkoff	33
10	Xenopus gamma-crystallin gene expression: evidence that the gamma-crystallin gene family is transcribed in lens and nonlens tissues. 1994 ·Molecular and Cellular Biology ·Beverly D. Smolich, (unknown), Margaret S. Saha, Robert M. Grainger	36
11	Xenopus γ-Crystallin Gene Expression: Evidence that the γ-Crystallin Gene Family Is Transcribed in Lens and Nonlens Tissues 1994 ·Molecular and Cellular Biology ·Beverly D. Smolich, (unknown), Margaret S. Saha, Robert M. Grainger	7
12	Wnt family proteins are secreted and associated with the cell surface. 1993 ·Molecular Biology of the Cell ·Beverly D. Smolich, Jill A. McMahon, Andrew P. McMahon, J Papkoff	142
13	Characterization of Xenopus laevis γ-crystallin-encoding genes 1993 ·Gene ·Beverly D. Smolich, (unknown), Margaret S. Saha, Dean G. Stathakis, Robert M. Grainger	21
14	Evolution and Mitochondrial DNA in Neurospora crassa 1986 ·Evolution ·John W. Taylor, Beverly D. Smolich, Georgiana May	18
15	EVOLUTION AND MITOCHONDRIAL DNA IN NEUROSPORA CRASSA 1986 ·Evolution ·John W. Taylor, Beverly D. Smolich, Georgiana May	49
16	Molecular cloning and physical mapping of the Neurospora crassa 74-OR23-1A mitochondrial genome 1985 ·Current Genetics ·John W. Taylor, Beverly D. Smolich	32
17	An evolutionary comparison of homologous mitochondrial plasmid DNAs from three Neurospora species 1985 ·Molecular and General Genetics MGG ·John W. Taylor, Beverly D. Smolich, Georgiana May	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact